We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.62%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$720M
AUM Growth
-$59.6M
(-7.6%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$4.08M |
| 2 |
JBTM
JBT Marel
JBTM
|
+$3.91M |
| 3 |
PRSU
Pursuit Attractions and Hospitality Inc
PRSU
|
+$3.66M |
| 4 |
Northern Oil and Gas
NOG
|
+$3.45M |
| 5 |
Devon Energy
DVN
|
+$3.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$7.07M |
| 2 |
Reliance Steel & Aluminium
RS
|
+$5.93M |
| 3 |
CHX
ChampionX
CHX
|
+$4.74M |
| 4 |
Accenture
ACN
|
+$4.11M |
| 5 |
On Holding
ONON
|
+$3.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Industrials | 15.79% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Natera
NTRA
$37.5B
| $937K | 0.13% |
+21,173
| New | +$1.08M |
|
202
Inspired Entertainment
INSE
$177M
| $932K | 0.13% |
77,913
-75,115
| -49% | -$961K |
|
203
Roivant Sciences
ROIV
$25.2B
| $931K | 0.13% |
79,694
-29,258
| -27% | -$331K |
|
204
Fidus Investment
FDUS
$737M
| $922K | 0.13% |
48,002
+1,730
| +4% | +$34.1K |
|
205
UFP Industries
UFPI
$4.97B
| $920K | 0.13% |
8,982
-355
| -4% | -$35.9K |
|
206
Western Alliance Bancorporation
WAL
$9.07B
| $906K | 0.13% |
19,703
+10,758
| +120% | +$508K |
|
207
Vertex
VERX
$1.92B
| $896K | 0.12% |
38,799
-45,399
| -54% | -$934K |
|
|
SPR
208
DELISTED
Spirit AeroSystems
SPR
| $887K | 0.12% |
54,940
| – | – |
|
|
PBPB
209
DELISTED
Potbelly
PBPB
| $882K | 0.12% |
113,040
-82,443
| -42% | -$702K |
|
210
H&R Block
HRB
$5.18B
| $882K | 0.12% |
20,472
-821
| -4% | -$30.3K |
|
211
Microvast
MVST
$267M
| $873K | 0.12% |
461,696
-30,763
| -6% | -$65.9K |
|
|
AVTA
212
DELISTED
Avantax, Inc. Common Stock
AVTA
| $862K | 0.12% |
33,691
-38,895
| -54% | -$922K |
|
213
Boyd Gaming
BYD
$6.47B
| $848K | 0.12% |
13,937
-1,193
| -8% | -$79.5K |
|
|
FL
214
DELISTED
Foot Locker
FL
| $845K | 0.12% |
+48,680
| New | +$1.09M |
|
215
Allegro MicroSystems
ALGM
$8.58B
| $807K | 0.11% |
+25,261
| New | +$1.03M |
|
|
NVO
216
Novo Nordisk
NVO
$216B
| $806K | 0.11% |
8,866
-5,442
| -38% | -$479K |
|
217
Mueller Industries
MLI
$14.1B
| $805K | 0.11% |
42,860
-57,592
| -57% | -$1.14M |
|
218
Green Brick Partners
GRBK
$3.13B
| $804K | 0.11% |
19,363
-36,126
| -65% | -$1.81M |
|
|
PETQ
219
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $785K | 0.11% |
+39,851
| New | +$713K |
|
220
MGP Ingredients
MGPI
$378M
| $779K | 0.11% |
7,384
-264
| -3% | -$29.9K |
|
221
IonQ
IONQ
$12.3B
| $767K | 0.11% |
51,537
+27,439
| +114% | +$431K |
|
222
Progress Software
PRGS
$1.55B
| $766K | 0.11% |
14,574
-560
| -4% | -$32.8K |
|
223
NRG Energy
NRG
$29.8B
| $754K | 0.1% |
19,584
-797
| -4% | -$30.2K |
|
224
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $750K | 0.1% |
10,270
-779
| -7% | -$62.2K |
|
225
Capital Southwest
CSWC
$1.46B
| $749K | 0.1% |
32,716
-4,097
| -11% | -$88.7K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q3 2023 Portfolio in Review
As of Q3 2023, Advisory Research held 510 positions worth $720M, down 7.6% from $780M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Advisory Research withdrew a net $36.5M in Q3 2023, closing 86 positions and reducing 203 holdings. Its most notable exit was Livent Corporation, an estimated $2.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Advisory Research opened a new position in JBT Marel worth $3.67M.
- Advisory Research's largest Q3 2023 buy was JBT Marel: 34,900 shares worth $3.67M.
- Advisory Research added most to GSK in Q3 2023, an estimated $4.08M increase.
- Advisory Research's biggest Q3 2023 reduction was Denbury Inc., cutting an estimated $7.07M.
- Advisory Research fully exited Livent Corporation in Q3 2023, selling an estimated $2.81M.
- Advisory Research's ten largest holdings make up 17% of its $720M portfolio in Q3 2023.
- Advisory Research opened 74 new positions and closed 86 in Q3 2023.
- Advisory Research's portfolio value fell 7.6% quarter-over-quarter to $720M.
Based on Advisory Research's 13F filing for Q3 2023, filed 13 Nov 2023.